Poll: Roughly 12% of US Adults Have Used a GLP-1 Drug, Even If Unaffordable

About 1 in 8 US adults aged 18 years or older report having ever used a glucagon-like peptide 1 (GLP-1) agonist medication, according to results from a KFF (formerly Kaiser Family Foundation) poll involving about 1500 respondents. This includes the 6% of people currently using a GLP-1 agonist such as semaglutide, marketed as Ozempic or Wegovy.